- Rating
- 2
- Confidence
- 3
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 2
Read review
Paper summary
This method uses Koopman theory to generate molecular trajectories, learning across different temporal strides and providing a flexible time grain for sampling trajectories. The results on different benchmarking datasets also suggest the effectiveness of the method.
Critical strengths
- The paper is well-written and well-organized.
- Applying the Koopman theory with a matrix constraint sounds reasonable for predicting further frames efficiently.
Critical weaknesses
-
This experiment lacks metrics related to ensemble and kinetics. Table 1 seems to miss several important Alphaflow metrics; I was wondering why the authors report only some of them instead of all of them. For kinetics, the paper only reports TICA in ATLAS. As a trajectory generation method, it would be better to report the performance on kinetics.
-
Some important baselines are missing, like PVB (ICLR 2026), EBA(ICML25) BIoMD(ICLR26), and DynaMode (ICML 2026 Workshop), especially the relevant method [1], which also uses the Koopman theory. More detailed discussion and comparison will make the paper convincing.
-
The conceptual novelty of the proposed method should be claimed more clearly.
[1]Sengar, Aditya, et al. "Beyond ensembles: simulating all-atom protein dynamics in a learned latent space." International Conference on Learning Representations. Vol. 2026. 2026.
Questions for authors
1.It seems that the Linear dynamics in the latent space is a Deterministic process; I was wondering if the model can get different replicas with the same initial conformation. 2. Did the A = JS constraint constrain the ability of the exploration to reach different meta states?
6 comments
[2/2] Response to Reviewer b6EQ
Response to Weakness 3 [Conceptual novelty]
The conceptual novelty of the proposed method should be claimed more clearly.
Response:
FlexMD proposed an EGNN-style molecular representation with a continuous-time latent generator, where preserves a learned quadratic form and gives an -norm bound on accumulation of latent discrepancies. The closed-form propagator can be evaluated at different lags, and the paper studies this framework across several molecular benchmarks. Our core contribution is proposing an organic framework with flexible-lag modeling, Koopman embeddings, and quadratic Hamiltonian structure and empirical evaluation on a variety of datasets.
Response to Question 1 [Different replicas]
It seems that the Linear dynamics in the latent space is a Deterministic process; I was wondering if the model can get different replicas with the same initial conformation.
Response:
Similar to most existing prior works, the same complete initial input produces the same trajectory, so the model cannot generate different replicas from an identical input. Different replicas could instead be obtained by varying the initial conformation or supplied momenta, or by introducing a stochastic component; we leave the exploration of these approaches to future work.
Response to Question 2 [Exploration of metastable states]
Did the A = JS constraint constrain the ability of the exploration to reach different meta states?
Response: Thank you for this question. On MD-CATH, where training includes MSM-guided pairs spanning metastable states, FlexMD achieves an MSM JSD of 0.17 ± 0.02, compared with 0.19 ± 0.00 for MARS-FM, suggesting that the constrained model can capture metastable-state distributions when relevant transitions are represented in the data. We conjecture that training-data coverage is an important factor in learning to reach different metastable states. At the same time, we think this constraint (A = JS) does not necessarily prevent transitions between metastable states: the encoder and decoder can place multiple physical states along the same latent trajectory.
Thanks for the response. I was wondering how you got the baseline results (mean ± std), especially for EBA, BioMD, and Sengar et. al. Are you training from scratch or using inference based on their checkpoint? Could you also report your results on the median, which aligns well with the baseline common setting?
[1/2] Response to Reviewer b6EQ
We thank the reviewer for the thoughtful and constructive assessment. We appreciate the recognition of the paper’s clear writing and organization, as well as the reviewer’s positive assessment of the constrained Koopman approach for efficient prediction of future frames. We have incorporated the corresponding revisions into the manuscript and highlighted them in blue.
Response to Weakness 1 [Ensemble and kinetic metrics]
Response:
Thanks for this suggestion. We have added ensemble metrics from AlphaFlow and autocorrelation (AutoCor) comparisons with reference MD to the revised manuscript. AutoCor assesses temporal correlations across lags and complements the existing tICA metric. As shown below, FlexMD achieves the best joint PCA distance and weak-contact similarity, competitive transient-contact similarity, and the lowest AutoCor deviations at longer lags; these results have been added to the revised manuscript.
Response to Weakness 2 [Missing baselines]
Response:
Thank you for suggesting these relevant baselines. We have added comparisons with PVB, EBA, BioMD, DynaMode, and Sengar et al. PVB uses a pretrained variational bridge; EBA aligns ensemble generation with physical feedback; BioMD combines forecasting and interpolation; and DynaMode generates trajectories through spectral diffusion. Sengar et al. is particularly relevant because it also draws on Koopman theory. To our knowledge, these methods have not explicitly demonstrated a single model trained across a range of physical lag times and conditioned on a selectable lag at inference. FlexMD addresses this setting using a continuous-time, quadratic-form-preserving Koopman generator.
We compare the methods on AdK and ATLAS.
For ATLAS, following the setting in Table 1, models are trained from scratch and evaluated at stride 40:
For AdK, following the setting in Table 4, models are trained from scratch at stride 5 and evaluated at the indicated test strides:
FlexMD achieves the lowest AdK prediction error at each reported test stride and the best mean performance on five of the seven ATLAS metrics. BioMD achieves higher global RMSF correlations, and EBA achieves a lower JSD; however, FlexMD still demonstrates excellent overall performance compared to these baselines. The comparison with Sengar et al. further shows that FlexMD performs well against another Koopman-based approach under these evaluation settings. We have added these experimental results to the revised manuscript.